companydata.dkcompanydata.dk

KEMIFARMA Consulting ApS: Financial statements 2023

CVR: 34709955

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,388,626 and a net result of DKK 662,880 compared with DKK 189,396 the year before. That is an increase of 27.6% compared with the year before. Equity in the 2023 report amounted to DKK 3,751,337. The solvency ratio was 94.7%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,388,626
Profit/Loss
DKK 662,880
Equity
DKK 3,751,337
Total Assets
DKK 3,963,142
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-1.4M663K3.8M1
2022-1.1M189K3.3M1
2021--122K410K3.1M-
2020--15K392K2.8M-
2019--32K176K2.4M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

KEMIFARMA Consulting ApS: The 2022 annual report is outMar 2, 2023

KEMIFARMA Consulting ApS has published its annual report for 2022. Gross profit came to DKK 1,088,484, and the net result was DKK 189,396.

About KEMIFARMA Consulting ApS

KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.

Source: annual report 2025, Danish Business Authority